| abstract |
The present invention relates to the use of proton pomp inhibitors in thermal ablation of cancer, and in particular to the use of proton pomp inhibitors encapsulated in liposomes. Furthermore, the invention relates to proton pomp inhibitors in acid solution, encapsulated in liposomes coated with polyethylene glycol or polysaccharides like dextran, and to pharmaceutical formulations containing them. |